The Federal Government introduced 60-day script dispensing at pharmacies which took effect on 1 September 2023.
To support pharmacy owners in regional, rural and remote Australia during the business transition for 60-day prescriptions, the Federal Government also introduced the Regional Pharmacy Transition Allowance (RPTA).
The program will run across four years, beginning on 1 September 2023 until 30 June 2027 and will provide an extra $148.2 million to support pharmacies in Modified Monash Model (MMM) 2-7 locations.
The new RPTA means over the next four years, eligible pharmacies dispensing 50,000 scripts annually may receive an extra:
Modified Monash Model 2 Locations
To be eligible to participate in the RPTA a pharmacy must:
Modified Monash Model 3-7 Locations
To be eligible to participate in the RPTA a pharmacy must:
Eligible pharmacies in MMM 3-7 may receive funding to largely offset the expected average dispensing related revenue loss:
Eligible pharmacies in MMM 2 may receive:
The below tables outline how much a pharmacy will receive, based on the script volume bands and Modified Monash Model classifications:
Modified Monash Model Classification |
||||||
April 22 to March 23
Script Volumes |
2 |
3 | 4 | 5 | 6 |
7 |
0 – 22,913 | $12,380 | $6,043 |
N/E |
|||
22,914 – 45,825 | $12,380 | $28,636 | $8,603 |
N/E |
||
45,826 – 57,282 | $12,380 | $45,399 | $30,591 | $14,164 |
N/E |
N/E |
57,283 – 68,738 | $12,380 | $56,959 | $44,265 | $32,027 | $17,316 |
N/E |
Modified Monash Model Classification |
||||||
April 22 to March 23
Script Volumes |
2 |
3 | 4 | 5 | 6 |
7 |
0 – 22,913 | $13,065 | $6,043 | $2,983 |
N/E |
||
22,914 – 45,825 | $13,065 | $72,552 | $55,128 | $36,274 | $12,816 |
N/E |
45,826 – 57,282 | $13,065 | $113,175 | $99,531 | $82,437 | $62,620 | $56,214 |
57,283 – 68,738 |
N/E |
$62,933 |
Modified Monash Model Classification |
||||||
April 22 to March 23
Script Volumes |
2 |
3 | 4 | 5 | 6 |
7 |
0 – 22,913 | $13,065 | $25,766 | $10,105 |
N/E |
||
22,914 – 45,825 | $13,065 | $80,426 | $69,848 | $49,821 | $29,125 | $4,733 |
45,826 – 57,282 | $13,065 | $126,880 | $113,732 | $151,793 | $78,851 | $73,724 |
57,283 – 68,738 |
N/E |
$52,444 |
Modified Monash Model Classification | ||||||
April 22 to March 23
Script Volumes |
2 |
3 | 4 | 5 | 6 |
7 |
0 – 22,913 | $13,065 | $22,857 | $10,910 |
N/E |
||
22,914 – 45,825 | $13,065 | $70,364 | $63,134 | $46,012 | $28,986 | $8,731 |
45,826 – 57,282 | $13,065 | $111,455 | $100,843 | $90,083 | $71,920 | $68,325 |
57,283 – 68,738 |
N/E |
$41,955 |
The Regional Pharmacy Transition Allowance is a new program and will be delivered by the Pharmacy Programs Administrator (PPA).
Pharmacies in Modified Monash Model 2-7 locations will need to register for the allowance through the Pharmacy Programs Administrator Portal. When registering, pharmacies in Modified Monash Model 3-7 locations will need to confirm they are currently receiving the Regional Pharmacy Maintenance Allowance when they register.
Registration for the Regional Pharmacy Transition Allowance program will be available in October 2023. Further information, including the program’s rules, will be made available on the PPA website in coming weeks.
The Regional Pharmacy Transition Allowance will commence on 1 September 2023, with registration being available via the PPA Portal in October 2023. The first payments will also be made to pharmacies in October 2023. Payments will be paid a month in arrears.
Pharmacies will not be entitled to claim for months where they weren’t registered for the program – for example, a pharmacy that registers in January 2024 will not be eligible to claim payments for September to December 2023.
Should you have any questions or need any help ensuring you receive all available assistance, please reach out to our team and we will endeavour to do our best to assist.
The team at Rose Partners